Drug development is an arduous and expensive exercise. We seek to produce innovative compounds efficiently and effectively.

SEC Filings

Filing	Description	Date Filed	Size
4	boger, joshua s	Nov 13, 2008	22.1 KB
4	boger, joshua s	Nov 6, 2008	22.6 KB
10-Q	quarterly report	Nov 5, 2008	434.0 KB
4	boger, joshua s	Oct 30, 2008	23.3 KB
8-K	current report	Oct 27, 2008	99.1 KB
4	boger, joshua s	Oct 23, 2008	22.7 KB
4	graves, kurt	Oct 22, 2008	20.6 KB
4	mueller, peter	Oct 16, 2008	22.5 KB
4	boger, joshua s	Oct 16, 2008	22.9 KB
4	alam, john j	Oct 2, 2008	21.6 KB
3	silva paul m	Sep 30, 2008	20.5 KB
8-K	current report	Sep 30, 2008	18.2 KB
CT ORDER	confidential treatment order	Sep 29, 2008	13.1 KB
CT ORDER	confidential treatment order	Sep 29, 2008	12.9 KB
8-K	current report	Sep 19, 2008	285.8 KB
4	mueller, peter	Sep 19, 2008	21.5 KB
424B5	prospectus filed pursuant to rule 424	Sep 18, 2008	307.4 KB
424B5	prospectus filed pursuant to rule 424	Sep 18, 2008	294.4 KB
S-3ASR	automatic shelf registration statement of securities of well-known seasoned issuers	Sep 17, 2008	120.1 KB
8-K	current report	Sep 12, 2008	18.2 KB
Showing 1-20 of 893 Page: 1 2 3 ... 45  Next 20